GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain
Niels Eijkelkamp(Utrecht University), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center)
Cited by 106
Related Papers
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain
|Journal of Clinical Investigation|2013|97
CD8+ T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain
|JCI Insight|2022|93